[Bioethical analysis of drugs advertisement and publicity].
This study investigates how advertising campaigns for drugs influence drug prescription practices among physicians from a point of view of "protection ethics" and of "intervention bioethics". It also analyzes information quality in advertisements for prescription drugs before and after the ANVISA (National Agency for Sanitary Protection) RDC 102/200 Resolution wich regulates drugs advertising as well as discusses the regulating role of the state in this area. A first approach was to interview 50 physicians in Brasília/DF (25 general physicians and 25 surgeons) in order to examine how they perceive the effects of advertisement on their professional activities. A second approach was to study 10 publicity pieces, five from before and five from after the RDC Resolution. The results showed that: a) 98% of phsicians are visited by sales representatives on a regular basis; b) 86% of physicians receive gifts during these visits; c) 68% beleive that advertising strongly influences prescription practices; d) 14% related prescription practices to the receival of rewards; e) 68% beleive that information contained in advertisements is unreliable; f) before the RDC Resolution, 28% of advertisements had adequate information content (counter-indications, indications precautions, warnings, and adverse reactions); after the RDC Resolution, that number grew to 79%.
Fagundes
Maria José Delgado
MJ
Anvisa - Agência Nacional de Vigilância Sanitária, UNESCO de Bioética da Universidade de Brasília. bioetica@unb.br
Soares
Magnely Gomes Alves
MG
Diniz
Nilza Maria
NM
Pires
Jansen Ribeiro
JR
Garrafa
Volnei
V
D000329:Advertising / Q000941:ethics*; D026688:Bioethical Issues; D001938:Brazil; D004345:Drug Industry / Q000941:ethics*